Gender differences in ankylosing spondylitis-associated cumulative healthcare utilization: A population-based cohort study

Clinics

Volumn 66, Issue 2, 2011, Pages 251-254

  Chen, Hsin Hua ^a,b,c   Chen, Tzeng Ji ^a,b   Chen, Yi Ming ^a,b   Ying Ming, Chiu ^c   Chen, Der Yuan ^a,b,c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Administrative database; Ankylosing spondylitis; Gender difference; Health care utilization; Population based study

Indexed keywords

ADOLESCENT; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; EPIDEMIOLOGY; FEMALE; HEALTH SERVICE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; SEX DIFFERENCE; SEX RATIO; STATISTICS; TAIWAN;

ADOLESCENT; ADULT; AGED; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; SEX DISTRIBUTION; SEX FACTORS; SPONDYLITIS, ANKYLOSING; TAIWAN; YOUNG ADULT;

EID: 79955496818     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000200012     Document Type: Article

References (23)

1. Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A. Ankylosing spondylitis: an overview. Ann Rheum Dis 2002;61 Suppl 3: 38-318.
2. Lee W, Reveille JD, Weisman MH. Women with ankylosing spondylitis: a review. Arthritis Rheum 2008;59:449-54, doi: 10.1002/art.23321.
3. Polley HF SC. Rheumatoid spondylitis: a study of 1,035 cases. Ann Intern Med 1947;26:240-249.
4. West HF. Aetiology of Ankylosing Spondylitis. Ann Rheum Dis 1949;8:143-148, doi: 10.1136/ard.8.2.143.
5. Masi AT, Wilkins WR. Does male:female sex ratio in ankylosing spondylitis change with age? J Rheumatol 1996;23:947-948.
6. Will R, Edmunds L, Elswood J, Calin A. Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men. J Rheumatol 1990;17:1649-1652.
7. Lee W, Reveille JD, Davis JC, Jr., Learch TJ, Ward MM, Weisman MH. Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis 2007;66:633-638, doi: 10. 1136/ard.2006.060293.
8. Boonen A, van der Heijde D, Landewe R, Guillemin F, Spoorenberg A, Schouten H, et al. Costs of ankylosing spondylitis in three European countries: the patient's perspective. Ann Rheum Dis 2003;62:741-747, doi:10.1136/ard.62.8.741.
9. Bureau of National Health Insurance. National Health Insurance Annual Statistical Report. Bureau of National Health Insurance, Taipei, Taiwan; 2001.
10. Chen TM. Taiwan's new national health insurance program: genesis and experience so far. Health Aff 2003;22:61-76, doi: 10.1377/hlthaff.22.3. 61.
11. D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson co-morbidity index with administrative data bases. J Clin Epidemiol 1996;49:1429-1433, doi: 10.1016/S0895-4356(96)00271-5.
12. Singh JA, Strand V. Health care utilization in patients with spondyloarthropathies. Rheumatology 2009;48:272-6, doi: 10.1093/rheumatology/ken472.
13. Lin TF. Modifiable health risk factors and medical expenditures - The case of Taiwan. Soc Sci Med 2008;67:1727-1736, doi: 10.1016/j.socscimed. 2008.09.010.
14. Verstappen SM, Jacobs JW, van der Heijde DM, van der Linden S, Verhoef CM, Bijlsma JW, et al. Utility and direct costs: ankylosing spondylitis compared with rheumatoid arthritis. Ann Rheum Dis 2007;66:727-731, doi: 10.1136/ard.2006.061283.
15. Roberts RO, Bergstralh EJ, Schmidt L, Jacobsen SJ. Comparison of selfreported and medical record health care utilization measures. J Clin Epidemiol 1996;49:989-995, doi: 10.1016/0895-4356(96)00143-6.
16. Kobelt G, Andlin-Sobocki P, Maksymowych WP. Costs and quality of life of patients with ankylosing spondylitis in Canada. J Rheumatol 2006;33:289-295.
17. Zink A, Thiele K, Huscher D, Listing J, Sieper J, Krause A, et al. Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 2006;33:86-90.
18. Boonen A, van der Heijde D, Landewe R, Guillemin F, Rutten-van Molken M, Dougados M, et al. Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries. Ann Rheum Dis 2003;62:732-40, doi: 10.1136/ard.62.8.732.
19. Boonen A, van den Heuvel R, van Tubergen A, Goossens M, Severens JL, van der Heijde D, et al. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis. Ann Rheum Dis 2005;64:396-402, doi: 10.1136/ard.2003.019711.
20. Charlson ME, Pompei P, Ales KL, McKenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies: Development and validation. J Chron Dis 1987;40:373-383, doi: 10.1016/0021-9681(87)90171-8.
21. Dominick KL, Dudley TK, Coffman CJ, Bosworth HB. Comparison of three co-morbidity measures for predicting health service use in patients with osteoarthritis. Arthritis Rheum 2005;53:666-672, doi: 10.1002/art.21440.
22. Liu CY, Liu JS. Socioeconomic and demographic factors associated with health care choices in Taiwan. Asia Pac J Public Health 2010;22:51-62.
23. Ward MM. Functional disability predicts total costs in patients with ankylosing spondylitis. Arthritis Rheum 2002;46:223-231, doi: 10.1002/ 1529-0131(200201)46:1,223::AID-ART498.3.0.CO;2-#.